Amara Raja Optimistic as BESS and Cell Line Ramp Nears

Amara Raja Energy & Mobility Limited — Q4 FY26 Earnings Call (May 26, 2026)

1. Overall Tone of Management: Optimistic

• Management highlights “good resilience” despite headwinds and repeatedly emphasizes growth momentum (e.g., “sustained demand momentum,” “robust growth,” “optimistic” on commissioning).
• They provide constructive forward-looking plans (BESS ramp, ESS integration facility, cell line milestones) and maintain margin targets (13–14% trajectory) with confidence, though with some hedging around volatility.

2. Key Themes from Management Commentary

• Lead acid momentum in India (automotive + tubular + home UPS):
• 4-wheeler OEM volumes >30% growth in the quarter; aftermarket ~5–6% (4W) and ~2–3% (2W).
• Tubular batteries >35% volume growth; 70–75% in-house manufacturing vs 20–25% trading.
• Export softness attributed to geopolitics/tariffs:
• “Muted growth” in automotive exports; exports are still a meaningful revenue contributor (~12% of FY26 revenue).
• Industrial lead acid mixed:
• Telecom lead acid declining due to transition to lithium, but telecom market share remains ~50%; UPS/industrial growth continues to support.
• New Energy business scaling + capex execution:
• New Energy revenue ~INR280 cr in Q4; telecom lithium packs supplied >300 MWh in the quarter.
• Additional investment into subsidiary: ~INR100 cr in Q4; total investment ~INR1,500 cr.
• Commissioning milestones: Customer Qualification Plant (CQP) expected to start full-scale operations in coming months; BESS facility expected to start production in Q4 FY26; first gigafactory under construction.
• Margin management under cost pressure:
• Consolidated EBITDA margin ~11% (standalone); Lead acid operating margin ~11.6%, and adjusted EBITDA ~12.3% when accounting for lithium trading revenue.
• Cost pressures: alloys + sulfuric acid inflation linked to geopolitical conflict; OEM mix shift (higher OEM share) impacting margins.
• Price actions: domestic automotive price increases ~5–6% in Q4; management signals more price increases may be needed due to FX depreciation and freight/raw material costs.
• Strategic pivot in New Energy mix toward ESS/BESS:
• “Major change in our strategy is the introduction of ESS as a larger part of our mix.”
• ESS integration facility in Divitipally: aiming production end of calendar year, initial capacity 5 GWh, ultimate 10 GWh.

3. Q&A Analysis

Theme A: Cell manufacturing execution & equipment readiness

• Core questions
• Status of equipment procurement for the 2 GWh cell line (commissioning next year): ordered vs procurement later?
• Constraints: equipment vs engineering/commissioning support.
• Management response
• Equipment already ordered.
• Main constraint is limited ability to get engineers from China for commissioning; visas limited, but engineers have been on-ground for months.
• Confidence in internal team capability; technology base acquired via cooperation; cylindrical 2170 program.
• Notable/strong points
• Clear operational explanation (equipment vs commissioning manpower), not a deferral.

Theme B: Gotion partnership / technology licensing viability

• Core questions
• Progress of Gotion tie-up; next steps for licensing and customer conversations.
• Whether approvals are needed from India/China governments.
• Management response
• Licensing discouraged by Chinese government; also challenges working directly on licensing/tie-ups with China.
• “No government approval” was sought because it was a corporate-to-corporate tie-up.
• LFP plants will be based on own technology; first capacity next year is NMC; LFP likely 2028 and later.
• Evasive/partial elements
• No concrete timeline for LFP beyond “2028 and later”; partnership progress is framed mainly as regulatory/China-driven constraints.

Theme C: BESS economics & margin expectations

• Core questions
• Expected margins once BESS plant stabilizes (initial 5 GWh).
• Management response
• Initial BESS margins: ~6%–7%.
• Upside possible with scale; also positions BESS as a strategic lever for deciding future cell manufacturing mix.
• Notable
• Provides a quantitative starting margin range (rare specificity).

Theme D: FY27 outlook for lead acid segments + raw material inflation

• Core questions
• FY27 outlook for replacement and industrial segments.
• Detailed raw material inflation: lead/alloys/plastics/sulfur; under-recovery; expected price hikes.
• Recycling benefit contribution.
• Management response
• Lead acid growth expectation: mid-to-high single digit; focus on quality of business and new solutions.
• Raw materials:
  • Lead + alloys ~70% of RM basket; plastics ~10% with potential ~40% price increase.
  • Sulfur drives acid prices; freight inbound/outbound rising.
  • Price increases: already took ~5–6% in Q4; may need another ~2%–3% price increase (not fully quantified beyond that).
• Recycling benefit:
  • Recycling accretion ~0.5% last quarter; battery breaking stabilization expected next quarter; RML prices rising may create offsetting pressure.
• Evasive/hedged
• Under-recovery and total cost recovery quantified only directionally; “not able to give a very quantified number” on price hike needs beyond the 2–3% directional view.

Theme E: New Energy demand visibility / off-take & ROCE

• Core questions
• Who buys incremental cell capacity from 2 GWh to 16 GWh? Any binding offtake?
• Cell cost vs imported cells; capex INR9,500 cr business case; ROCE underwriting.
• Risk that localization mandates raise customer costs and slow adoption.
• Management response
• India offtake: 2170 capacity based on own market assessment; not expecting big “firm” offtake deals like abroad.
• For 16 GWh: mix shift—EV OEM programs with some take-or-pay-like safeguards; for ESS, company is the end user (5 GWh ESS plant).
• Cost competitiveness: not aiming to be cheaper than China; minimum bridge China + 15% to 20% initially.
• Returns:
  • At 8–10 GWh scale, potential EBITDA margin ~10%–11%.
  • ROCE: “low double-digit” but no exact number; capex per GWh assumed $55–$60m initially, now down ~20%–25%.
• Localization cost risk: acknowledges possible slowdown risk, but argues uniform industry cost increases are “baked in” and won’t fully destabilize growth.
• Credibility signals
• Provides some quantitative targets (EBITDA margin range, China+15–20% bridge), but ROCE remains non-specific.

Theme F: Lead acid long-term utilization risk (EV penetration)

• Core questions
• Could lead acid facilities become underutilized as EV penetration rises?
• How to handle transition over 2–3 years and 10 years.
• Management response
• Still expects ability to reach 13%–14% EBITDA margin even at high lead base via throughput and cost pass-through lag.
• On utilization: telecom lead acid declines, but tubular demand and home applications provide runway; ICE/ICE replacement cycle + car parc replacement supports lead acid.
• Explicitly argues EV leapfrogging is unlikely for India now; hybrids should be accelerated.
• Strong framing
• Addresses capacity redundancy directly and ties it to replacement cycle rather than just current demand.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Q4 FY26 performance
• Consolidated revenue: ~INR 3,530 cr (~15% YoY).
• New Energy revenue: ~INR 280 cr.
• FY26 full year
• Consolidated revenue: INR 13,814 cr (~7.5% YoY).
• Consolidated margin: EBITDA ~10.8%; Lead acid operating margin ~12.2%.
• Capex
• FY27 capex: INR 1,500–1,700 cr
  • Lead acid: ~INR 400 cr
  • New Energy: ~INR 1,100–1,200 cr
• BESS / ESS
• ESS integration facility in Divitipally:
  • Start production: end of calendar year
  • Capacity: 5 GWh initial, ultimate 10 GWh
• BESS plant initial stabilized margins: ~6%–7%, upside with scale.
• Cell manufacturing
• Equipment ordered; commissioning constraints are engineering/visas.
• First gigafactory line (Giga 1): production expected June 2027.
• LFP capacity: 2028 and later (NMC first capacity next year).
• Lead acid pricing
• Potential additional price increase: ~2%–3% directional view (subject to competition and cost trajectory).
• FY27 growth
• Lead acid growth: mid-to-high single digit (qualitative but consistently stated as a numeric band).

Implicit signals (qualitative)

• More price increases likely if FX/freight/raw material pressures persist (“might force us to look at some more price increases”).
• Export revival hoped in coming quarters after muted geopolitical impact.
• New Energy mix shift: ESS/BESS becoming a larger part of growth strategy; EV remains steady but not the sole driver.
• Margin trajectory confidence: management still targets 13%–14% EBITDA over time, but admits volatility makes timing uncertain.

5. Standout Statements (direct / high-signal)

• Strategy shift (New Energy): “Major change in our strategy is the introduction of ESS as a larger part of our mix.”
• Commissioning confidence: “optimistic that our ability to start delivering commercial samples… in the next couple of months.”
• Cell line constraint clarity: “equipment has been ordered… bigger challenge… limitations in getting the engineers from China to come and help…”
• BESS margin anchor: “Operating margins could be around… 6% to 7% to start with.”
• Cost competitiveness stance: “We’re not going to be cost competitive with a product that’s imported from China.”
• Localization/returns bridge: “China plus 15% to 20% is the minimum that we can bridge immediately.”
• Margin target reaffirmation: “13% to 14% kind of an EBITDA margin… still on the horizon.”
• EV vs hybrids narrative: “the thought that we can completely leapfrog from ICE to EV… not something that’s making so much sense for India right now. Hybrid definitely is required.”

6. Red Flags / Positive Signals

Red flags
– ROCE not quantified despite being asked directly; “low double-digit” only.
– Cost recovery uncertainty: repeated hedging on how much price hikes are needed; “not able to give… quantified number.”
– Export weakness persists and is attributed to geopolitics/tariffs; no firm recovery timeline.
– China dependency risk remains for cell commissioning (engineers/visas), even if equipment is ordered.

Positive signals
– Operational milestones are specific (CQP commissioning, BESS production timing, Giga 1 June 2027).
– Clear margin bridge logic for lead acid (throughput leverage + cost pass-through lag).
– Quantified BESS margin range and New Energy scale assumptions (8–10 GWh for EBITDA margin 10–11%).
– Demand momentum in tubular batteries and home UPS is strong and supported by in-house manufacturing share.

7. Historical Comparison & Consistency Analysis (vs prior calls)

a. Change in Tone Over Time

• Current (Q4 FY26): More Optimistic—management emphasizes resilience, sustained demand, and multiple commissioning milestones.
• Prior (Q4 FY25 / Q1 FY26): More cautious/defensive around margins and power/material costs.
• Q1 FY26: margins “subdued” due to material cost, power/employee costs, warranty provisioning, and trading mix.
• Q4 FY25: margins impacted by material + power costs; target to improve back to 14%.
• Shift classification: More Optimistic
• Language moved from “headwinds persisting” to “momentum,” “optimistic,” and clearer execution timelines.

b. Tracking Past Commitments vs Outcomes

• Tubular battery ramp / trading normalization
• Prior (Q1 FY26): tubular factory commenced; expectation that trading mix would reduce as manufacturing ramps.
• Current (Q4 FY26): tubular volumes >35% growth; 70–75% in-house manufacturing; trading still 20–25%.
• Assessment: ✅ Partially delivered (improvement in in-house share, but trading not fully eliminated).
• Power cost resolution timeline
• Q1 FY26: CFO expected power issues to settle by end of Q1 / beginning of Q3.
• Current: still references cost pressures (raw materials, freight, FX), but no explicit “power cost” crisis narrative like earlier.
• Assessment: ✅ Likely improved (power not highlighted as the dominant driver in Q4 FY26 commentary).
• Cell manufacturing timeline
• Q1 FY26: end of FY27 for manufacturing capacity; NMC first.
• Current: Giga 1 production expected June 2027; equipment ordered; commissioning constraints mainly engineering manpower.
• Assessment: ✅ On track (timing consistent with prior end-FY27 guidance).

c. Narrative Shifts

• New Energy emphasis changed:
• Q4 FY25/Q1 FY26: EV/charger and telecom ESS growth were central; ESS discussed but not as dominant.
• Current: explicit ESS/BESS mix shift and ESS integration facility capacity planning.
• Risk framing changed:
• Earlier calls: heavy focus on power cost adjustments and margin suppression.
• Current: focus shifted to raw material inflation (alloys/sulfuric acid), FX/freight, and OEM mix—less on power settlement issues.

d. Consistency & Credibility Signals

• Medium credibility (improving but not fully consistent)
• Positives: commissioning timelines (CQP, Giga 1) are consistent; margin target reaffirmed repeatedly.
• Concerns: margin recovery depends on price actions and cost volatility; ROCE remains non-quantified for large capex plans.

e. Evolution of Key Themes

• Demand (Improving/Stable): tubular + home UPS momentum strong in Q4 FY26; automotive aftermarket steady.
• Margins (Stable-to-Improving but volatile): moved from “subdued” (Q1 FY26) to “operating margin ~12% lead acid” with continued cost pressure.
• Localization/regulation (Increasing emphasis): now used as a strategic lever for ESS/utility scale and returns.
• New Energy strategy (Inflecting): ESS becomes a larger part of the mix; LFP timing pushed to 2028+.

f. Additional Insights (Cross-Period Intelligence)

• A quiet build-up of execution risk: while equipment is ordered and milestones are maintained, the Q4 FY26 Q&A reveals a persistent dependency on China-based engineers/visas for commissioning—this is a practical bottleneck that can affect timelines even if capex is committed.
• Return narrative remains conditional: management provides EBITDA margin targets at scale but avoids firm ROCE numbers, suggesting business-case sensitivity to cost, localization policy, and ramp efficiency.